Activity Description:

Alcoholic liver disease impacts patients across all demographics and is found in communities of all sizes. Awareness of alcoholic liver disease and the clinical guidelines for liver transplantation is the cornerstone of appropriate and timely care for this patient population. Understanding the signs of alcohol liver disease and the treatment options available is vital to equipping providers to best address the needs of these patients.

Target Audience: 

Specialties - Internal Medicine

Professions - Physician

Learning Objectives:

• Identify the indications and contraindications for new modalities in the prevention, diagnosis, and treatment of Internal Medicine conditions.
• Formulate prioritized differential diagnoses for the clinical presentations of specific medical conditions, diagnoses, and diseases.
• Apply clinical guidelines to patients under their care with an understanding of the rationale behind the guidelines and the expected outcomes of specific medical conditions, diagnoses, diseases.
• Integrate research techniques related to specific medical conditions, diagnoses, and diseases, into their own clinical, translational or basic science research.

Moderator:

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.